Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Market Update

Julia Lee
December 28, 2017

Market Update

Julia Lee
December 28, 2017

Market Update 27 December

Julia Lee
December 27, 2017

Market Update 22 Dec

Julia Lee
December 22, 2017

Market Update

Julia Lee
December 21, 2017

Market Update 20 december

Julia Lee
December 20, 2017

Market Update

Julia Lee
December 18, 2017

Market Update

Julia Lee
December 15, 2017

Market Update

Julia Lee
December 13, 2017